Archive for May 4th, 2012

MAPP on target to meet FDA 2Q regarding CRL. GENT MAA update. VICL files $150m shelf + ISIS

May 04, 2012 No Comments by

Vical Incorporated (Nasdaq: VICL) filed a mixed shelf allowing it to issue common stock and preferred stock, debt securities and/or warrants, either individually or in combination, with a total value of up to $150,000,000 from time to time. Gentium S.p.A. (Nasdaq:GENT) announced today that it has received the Day 180 List of Outstanding Issues (the “LoOIs”) […]

Daily News Read more

ALXA issued CRL. SGYP offering. Pipeline updates for OGXI NGSX ANTH ZIOP THLD EXEL DRRX

May 04, 2012 No Comments by

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that it has received a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for ADASUVE. In its press release the company said the CRL was issued due to medical device deficiencies and plans to meet with the FDA to resolve the issues. Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) […]

Daily News Read more